Efficacy of Gamma Auditory Stimulation for Cognitive Decline in Older Adults (Study 1)
NCT: NCT07087951 · RECRUITING
Brief Summary
Animal studies have shown that 40 Hz auditory stimulation alone can improve spatial memory and reduce Aβ deposition. However, human studies using 40 Hz auditory stimulation alone remain limited. Therefore, this study will use a randomized, double-blind, placebo-controlled design to investigate the effects of 40 Hz auditory stimulation on cognitive function, EEG activity, sleep quality, and quality of life in older adults with mild cognitive impairment (MCI) or mild dementia.
Frequently Asked Questions
What is Efficacy of Gamma Auditory Stimulation for Cognitive Decline in Older Adults (Study 1)?
Efficacy of Gamma Auditory Stimulation for Cognitive Decline in Older Adults (Study 1) is a clinical trial registered under NCT07087951. Current status: RECRUITING.
What is the status of NCT07087951?
The current status of NCT07087951 (Efficacy of Gamma Auditory Stimulation for Cognitive Decline in Older Adults (Study 1)) is: RECRUITING.
When did Efficacy of Gamma Auditory Stimulation for Cognitive Decline in Older Adults (Study 1) start?
Efficacy of Gamma Auditory Stimulation for Cognitive Decline in Older Adults (Study 1) started on 2025-11-14.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.